# Patient Preference and Long-term Outcomes in Persistent Spinal Pain Syndrome: A Prospective Study Comparing Spinal Cord Stimulation to Intrathecal Drug Delivery.

> **NCT07091123** · PHASE4 · RECRUITING · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 36 (estimated)

## Conditions studied

- Persistent Spinal Pain Syndrome

## Interventions

- **DEVICE:** Pain pump
- **DRUG:** Bupivacain 0.625%/Fentanyl 2mcg/ml
- **DEVICE:** Spinal Cord Stimulator (SCS)

## Key facts

- **NCT ID:** NCT07091123
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-13
- **Primary completion:** 2027-08-11
- **Final completion:** 2027-08-11
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07091123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07091123, "Patient Preference and Long-term Outcomes in Persistent Spinal Pain Syndrome: A Prospective Study Comparing Spinal Cord Stimulation to Intrathecal Drug Delivery.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07091123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*